SRARP and breast cancer: To test whether ERRF expression improves the therapeutic response of ERBB2 positive breast cancer to lapatinib, JIMT-1 cells stably expressing ERRF and the vector control were subcutaneously injected into nude mice, lapatinib treatment was applied subsequently, and tumor growth was analyzed.